The Bethesda system for reporting thyroid cytopathology: A meta-analysis

Acta Cytologica

Volumn 56, Issue 4, 2012, Pages 333-339

  Bongiovanni, Massimo ^a   Spitale, Alessandra ^a   Faquin, William C ^b   Mazzucchelli, Luca ^a   Baloch, Zubair W ^c  

^a INSTITUTE OF PATHOLOGY   (Switzerland)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bethesda; Meta analysis; Thyroid fine needle aspiration

Indexed keywords

ASPIRATION BIOPSY; BETHESDA SYSTEM; CORRELATION ANALYSIS; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; EXCISION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FOLLOW UP; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THYROID GLAND; VALIDATION STUDY;

EID: 84864186974     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000339959     Document Type: Review

References (35)

1. Mazzaferri EL: Management of a solitary thyroid nodule. N Engl J Med 1993;328:553-559.
2. Gharib H, Papini E, Valcavi R, Baskin HJ, Crescenzi A, Dottorini ME, Duick DS, Guglielmi R, Hamilton CR Jr, Zeiger MA, Zini M: American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 2006;12:63-102.
3. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM: Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-1214.
4. Ries LAG, Melbert D, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2005. Bethesda, National Cancer Institute, 2007. http://seer.cancer.gov/ csr/1975-2005/
5. Chen AY, Jemal A, Ward EM: Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009;115:3801-3807.
6. Hassell LA, Gillies EM, Dunn ST: Cytologic and molecular diagnosis of thyroid cancers: Is it time for routine reflex testing? Cancer Cytopathol 2011;120:7-17.
7. Ross DS: Predicting thyroid malignancy (editorial). J Clin Endocrinol Metabol 2006;91:4253-4255.
8. Ali SZ, Cibas ES: The Bethesda System for Reporting Thyroid Cytopathology. Definitions, criteria and explanatory notes. New York, Springer, 2010.
9. Abele JS, Levine RA: Diagnostic criteria and risk-adapted approach to indeterminate thyroid cytodiagnosis. Cancer Cytopathol 2010;118:415-422.
10. Marhefka GD, McDivitt JD, Shakir KM, Drake AJ 3rd: Diagnosis of follicular neoplasm in thyroid nodules by fine needle aspiration cytology: does the result, benign vs. suspicious for a malignant process, in these nodules make a difference? Acta Cytol 2009;53:517-523.
11. Miller B, Burkey S, Lindberg G, Snyder WH 3rd, Nwariaku FE: Prevalence of malignancy within cytologically indeterminate thyroid nodules. Am J Surg 2004;188:459-462.
12. Pang T, Ihre-Lundgren C, Gill A, McMullen T, Sywak M, Sidhu S, Delbridge L: Correlation between indeterminate aspiration cytology and final histopathology of thyroid neoplasms. Surgery 2010;148:532-537.
13. Poller DN, Ibrahim AK, Cummings MH, Mikel JJ, Boote D, Perry M: Fine-needle aspiration of the thyroid. Cancer 2000;90:239-244.
14. Rabaglia JL, Kabbani W, Wallace L, Holt S, Watumull L, Pruitt J, Snyder WH, Nwariaku FE: Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions. Surgery 2010;148:1267-1272.
15. Redman R, Yoder BJ, Massoll NA: Perceptions of diagnostic terminology and cytopathologic reporting of fine-needle aspiration biopsies of thyroid nodules: a survey of clinicians and pathologists. Thyroid 2006;16:1003-1008.
16. Yoder BJ, Redman R, Massoll NA: Validation of a five-tier cytodiagnostic system for thyroid fine needle aspiration biopsies using cytohistologic correlation. Thyroid 2006;16:781-786.
17. Jo VY, Stelow EB, Dustin SM, Hanley KZ: Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 2010;134:450-456.
18. Renshaw AA: Should 'atypical follicular cells' in thyroid fine-needle aspirates be subclassified? Cancer Cytopathol 2010;118:186-189.
19. Nayar R, Ivanovic M: The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer Cytopathol 2009;117:195-202.
20. Theoharis CG, Schofield KM, Hammers L, Udelsman R, Chhieng DC: The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid 2009;19:1215-1223.
21. Kim SK, Hwang TS, Yoo YB, Han HS, Kim DL, Song KH, Lim SD, Kim WS, Paik NS: Surgical results of thyroid nodules according to a management guideline based on the braf (v600e) mutation status. J Clin Endocrinol Metabol 2011;96:658-664.
22. Her-Juing Wu H, Rose C, Elsheikh TM: The Bethesda system for reporting thyroid cytopathology: an experience of 1, 382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy. Diagn Cytopathol 2012;40:399-403.
23. Bongiovanni M, Crippa S, Baloch Z, Piana S, Spitale A, Pagni F, Mazzucchelli L, Di Bella C, Faquin W: Comparison of 5-tiered and 6-tiered diagnostic systems for the reporting of thyroid cytopathology: a multi-institutional study. Cancer Cytopathol 2012;120:117-125.
24. Bohacek L, Milas M, Mitchell J, Siperstein A, Berber E: Diagnostic accuracy of surgeonperformed ultrasound-guided fine-needle aspiration of thyroid nodules. Ann Surg Oncol 2012;19:45-51.
25. Cibas ES, Ali SZ: The Bethesda system for reporting thyroid cytopathology. Thyroid 2009;19:1159-1165.
26. Cibas ES, Ali SZ: The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 2009;132:658-665.
27. British Thyroid Association, Royal College of Physicians: Guidelines for Management of Thyroid Cancer. Report of the thyroid cancer guidelines update group, ed 2. London, Royal College of Physicians, 2007.
28. Fadda G, Basolo F, Bondi A, Bussolati G, Crescenzi A, Nappi O, Nardi F, Papotti M, Taddei G, Palombini L: Cytological classification of thyroid nodules. Proposal of the SIAPEC-IAP Italian consensus working group. Pathologica 2010;102:405-408.
29. Ali SZ: Thyroid cytopathology: Bethesda and beyond. Acta Cytol 2011;55:4-12.
30. Renshaw AA: Non-diagnostic rates for thyroid fine needle aspiration are negatively correlated with positive for malignancy rates. Acta Cytol 2011;55:38-41.
31. Frates MC, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman BG, Cronan JJ, Doubilet PM, Evans DB, Goellner JR, Hay ID, Hertzberg BS, Intenzo CM, Jeffrey RB, Langer JE, Larsen PR, Mandel SJ, Middleton WD, Reading CC, Sherman SI, Tessler FN: Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Ultrasound Q 2006;22:231-238.
32. Baloch Z, LiVolsi VA, Jain P, Jain R, Aljada I, Mandel S, Langer JE, Gupta PK: Role of repeat fine-needle aspiration biopsy (FNAB) in the management of thyroid nodules. Diagn Cytopathol 2003;29:203-206.
33. Krane JF, Vanderlaan PA, Faquin WC, Renshaw AA: The atypia of undetermined significance/follicular lesion of undetermined significance: malignant ratio: a proposed performance measure for reporting in the Bethesda system for thyroid cytopathology. Cancer Cytopathol 2012;120:111-116.
34. Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN: Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1, 056 FNA samples. J Clin Endocrinol Metabol 2011;96:3390-3397.
35. Chudova D, Wilde JI, Wang ET, Wang H, Rabbee N, Egidio CM, Reynolds J, Tom E, Pagan M, Rigl CT, Friedman L, Wang CC, Lanman RB, Zeiger M, Kebebew E, Rosai J, Fellegara G, LiVolsi VA, Kennedy GC: Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metabol 2010;95:5296-5304.